Nyxoah to Release Third Quarter 2026 Financial Results on November 5, 2026 Read more about Nyxoah to Release Third Quarter 2026 Financial Results on November 5, 2026
Full 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026 Read more about Full 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026
Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System Read more about Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System
Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026 Read more about Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026
Nyxoah Announces Preliminary Results for the Second Quarter of 2026 Read more about Nyxoah Announces Preliminary Results for the Second Quarter of 2026
Nyxoah to Host Investor Day in New York on July 8, 2026 Read more about Nyxoah to Host Investor Day in New York on July 8, 2026
Nyxoah Receives $15 Million from the European Investment Bank Read more about Nyxoah Receives $15 Million from the European Investment Bank
Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology Read more about Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology
$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch Read more about $110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch
Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum Read more about Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum